- Home
- ALT vs ACNB Comparison
ALT vs ACNB Comparison
Compare ALT & ACNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALT
- ACNB
- Stock Information
- Founded
- ALT 1997
- ACNB 1857
- Country
- ALT United States
- ACNB United States
- Employees
- ALT N/A
- ACNB N/A
- Industry
- ALT Biotechnology: Pharmaceutical Preparations
- ACNB Major Banks
- Sector
- ALT Health Care
- ACNB Finance
- Exchange
- ALT Nasdaq
- ACNB Nasdaq
- Market Cap
- ALT 397.4M
- ACNB 450.1M
- IPO Year
- ALT N/A
- ACNB N/A
- Fundamental
- Price
- ALT $4.19
- ACNB $42.84
- Analyst Decision
- ALT Strong Buy
- ACNB Strong Buy
- Analyst Count
- ALT 6
- ACNB 4
- Target Price
- ALT $18.20
- ACNB $50.00
- AVG Volume (30 Days)
- ALT 11.7M
- ACNB 35.6K
- Earning Date
- ALT 08-07-2025
- ACNB 07-23-2025
- Dividend Yield
- ALT N/A
- ACNB 3.08%
- EPS Growth
- ALT N/A
- ACNB N/A
- EPS
- ALT N/A
- ACNB 2.79
- Revenue
- ALT $20,000.00
- ACNB $113,448,000.00
- Revenue This Year
- ALT N/A
- ACNB $38.67
- Revenue Next Year
- ALT $1,557,547.90
- ACNB $5.26
- P/E Ratio
- ALT N/A
- ACNB $15.82
- Revenue Growth
- ALT N/A
- ACNB 8.66
- 52 Week Low
- ALT $2.90
- ACNB $35.28
- 52 Week High
- ALT $11.16
- ACNB $50.72
- Technical
- Relative Strength Index (RSI)
- ALT 39.67
- ACNB 50.00
- Support Level
- ALT $4.33
- ACNB $43.87
- Resistance Level
- ALT $4.79
- ACNB $45.10
- Average True Range (ATR)
- ALT 0.52
- ACNB 1.00
- MACD
- ALT -0.16
- ACNB 0.08
- Stochastic Oscillator
- ALT 26.92
- ACNB 48.52
About ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.